Department of Public Health, Hjelt Institute, University of Helsinki, Helsinki, Finland.
Cardiovasc Diabetol. 2012 Jun 25;11:76. doi: 10.1186/1475-2840-11-76.
Individuals who had normoglycemia but whose 2-hour plasma glucose (2hPG) concentrations did not return to the fasting plasma glucose (FPG) levels during an oral glucose tolerance test (OGTT) have been shown to have increased cardiovascular mortality. This is further investigated regarding to the first events of coronary heart disease (CHD) and ischemic stroke (IS).
Data from 9 Finnish and Swedish cohorts comprising 3743 men and 3916 women aged 25 to 90 years who had FPG < 6.1 mmol/l and 2hPG < 7.8 mmol/l and free of CVD at enrollment were analyzed. Hazard ratios (HRs) for first CHD and IS events were estimated for the individuals with 2hPG > FPG (Group II) compared with those having 2hPG ≤ FPG (Group I).
A total of 466 (115) CHD and 235 (106) IS events occurred in men (women) during a median follow-up of 16.4 years. Individuals in Group II were older and had greater body mass index, blood pressure, 2hPG and fasting insulin than those in Group I in both sexes. Multivariate adjusted HRs (95% confidence intervals) for incidence of CHD, IS, and composite CVD events (CHD + IS) in men were 1.13 (0.93-1.37), 1.40 (1.06-1.85) and 1.20 (1.01-1.42) in the Group II as compared with those in the Group I. The corresponding HRs in women were 1.33 (0.83-2.13), 0.94 (0.59-1.51) and 1.11 (0.79-1.54), respectively.
Within normoglycemic range individuals whose 2hPG did not return to their FPG levels during an OGTT had increased risk of CHD and IS.
在口服葡萄糖耐量试验(OGTT)期间,2 小时血浆葡萄糖(2hPG)浓度未恢复到空腹血浆葡萄糖(FPG)水平的个体,其心血管死亡率已被证明有所增加。本研究进一步探讨了其与首次冠心病(CHD)和缺血性卒中(IS)事件的关系。
分析了来自芬兰和瑞典的 9 个队列,共纳入 3743 名年龄在 25 至 90 岁之间的男性和 3916 名女性,这些人在入组时 FPG<6.1mmol/l,2hPG<7.8mmol/l,且无 CVD。对于 2hPG>FPG(组 II)的个体,与 2hPG≤FPG(组 I)的个体相比,估计了首次 CHD 和 IS 事件的风险比(HR)。
在中位随访 16.4 年后,男性(女性)共发生 466(115)例 CHD 和 235(106)例 IS 事件。与组 I 相比,组 II 中的个体年龄更大,体重指数、血压、2hPG 和空腹胰岛素水平更高。男性中,CHD、IS 和复合 CVD 事件(CHD+IS)的多变量校正 HR(95%置信区间)在组 II 中分别为 1.13(0.93-1.37)、1.40(1.06-1.85)和 1.20(1.01-1.42),而在组 I 中分别为 1.33(0.83-2.13)、0.94(0.59-1.51)和 1.11(0.79-1.54)。女性中的相应 HR 分别为 1.33(0.83-2.13)、0.94(0.59-1.51)和 1.11(0.79-1.54)。
在血糖正常范围内,OGTT 期间 2hPG 未恢复到 FPG 水平的个体,其 CHD 和 IS 风险增加。